Delivery Order SPE2DB22D1017-SPE2DB24FG2ER

Award Date 7/30/24
Potential Completion Date 7/31/24
Potential Value $2.7K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award is to Amerisourcebergen Drug Corp's Corporate Office Division, a major supplier of pharmaceutical products and medical supplies to the U.S. government. The contract, valued at $2,720.86, is for the delivery of the pharmaceutical product LO LOESTRIN FE 1-10 TABLET 28S to the Defense Logistics Agency (DLA) Troop Support Medical. The contract is a Delivery Order under Amerisourcebergen's Indefinite Delivery Contract (IDC) with the DLA, worth up to $999,999,999.00 through...
This federal contract award is a delivery order issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, which has a firm fixed-price, Ceiling Value of $4,388.56, is for the delivery of Lo Loestrin Fe 1-10 Tablet 28s. The award does not have a set-aside designation, indicating open competition. AmerisourceBergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA...
This federal contract award is a $5,149.80 Firm Fixed Price Delivery Order from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract is for the pharmaceutical product "LO LOESTRIN FE 1-10 TABLET 28S" and has an ultimate completion date of November 26, 2024. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical that serves as a primary vehicle for providing a...
This federal contract award to Amerisourcebergen Drug Corp's Corporate Office Division, a major pharmaceutical distributor, is for the delivery of the prescription drug LO LOESTRIN FE 1-10 TABLET 28S to the Defense Logistics Agency (DLA). The contract has a ceiling value of $1,312.60 and a completion date of July 10, 2024. Amerisourcebergen holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued up to $999,999,999.00 through December 31, 2025. This...
This federal contract award is a delivery order from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $3,612.92 firm-fixed-price contract is for the delivery of the medication LO LOESTRIN FE 1-10 TABLET 28S, with a performance period ending on June 9, 2025. AmerisourceBergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999.00. This...
This federal contract award is for the delivery of the pharmaceutical product LO LOESTRIN FE 1-10 TABLET 28S to the Defense Logistics Agency (DLA), a defense agency. The contract, valued at $1,098.24, was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a Delivery Order with a Firm Fixed Price pricing type and has an ultimate completion date of October 24, 2024. The award is part of a larger Indefinite Delivery Contract...
This federal contract award to Amerisourcebergen Drug Corp's Corporate Office Division is a delivery order under the company's Indefinite Delivery Contract (IDC) with the Defense Logistics Agency (DLA) Troop Support Medical, valued up to $999,999,999.00 through December 31, 2025. The order is for the provision of 4,564,437,675 tablets of the prescription drug Lo Loestrin Fe 1-10. The award has a ceiling value of $1,194.60 and a completion date of April 30, 2024. Amerisourcebergen, a major...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $8,064.98 firm-fixed-price delivery order contract is for the supply of the medication Lo Loestrin Fe 1-10 Tablet 28s. The contract has an ultimate completion date of January 31, 2023 and is not designated with a set-aside requirement, indicating open competition. Amerisourcebergen holds a $999,999,999 Indefinite...
This is a $1,857.36 firm fixed-price delivery order awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, by the Defense Logistics Agency. The order is for the drug Lo Loestrin Fe 1-10 Tablet 28s and has a completion date of June 23, 2025. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the Defense Logistics Agency Troop Support Medical, valued at $999,999,999.00, which provides a comprehensive global pharmaceutical support vehicle through...
This federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, is a delivery order under a larger Indefinite Delivery Contract (IDC) with the Defense Logistics Agency (DLA) Troop Support Medical. The $6,093.99 firm fixed-price contract is for the supply of the pharmaceutical product LO LOESTRIN FE 1-10 TABLET 28S. This delivery order is part of a $999,999,999 IDC with the DLA that provides a comprehensive range of pharmaceutical and medical products to support...
  • SPE2DB22D1017
    Indefinite Delivery Contract
  • SPE2DB22D1017-SPE2DB24FG2ER
    Delivery Order

This federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, is a Delivery Order valued at $2,693.15 for the supply of the prescription drug Lo Loestrin FE 1-10 Tablet 28s. The contract was awarded by the Defense Logistics Agency (DLA), a component of the U.S. Department of Defense, and has an ultimate completion date of July 31, 2024. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at up to $999,999,999 through December 2025, for delivering a range of medical commodities to support military treatment programs and facilities worldwide. This award does not have a set-aside designation and is a firm fixed-price contract.

Generated 10/29/24, 9:08 AM